Pharmaceuticals Recalls Cephradine Capsules
FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
June 30, 1999
Sellersville, PA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Teva Pharmaceuticals, USA, Inc. is recalling
Cephradine Capsules because of Subpotency (stability).
Cephradine Capsules USP, 250 mg in bottles of 100, Rx
indicated in the treatment of respiratory tract infection, otitis media, skin and
skin-structure infections, and urinary tract infections. NDC #0093-3153-01.
Lot #56214 EXP 9/99.
Teva Pharmaceuticals, USA, Inc., Sellersville, Pennsylvania.
Manufacturer, by letter on June 15, 1999. Firm-initiated recall ongoing.
Approximately 10,852 bottles were distributed; firm estimated that 2,700 bottles
remained on market at time of recall initiation.